Mishra Vaishnavi H, Gupta Pratham, Bankar Nandkishor J, Noman Obaid
Department of Microbiology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Nagpur, Maharashtra, India.
Department of Microbiology, Datta Meghe Medical College, Datta Meghe Institute of Higher Education and Research, Nagpur, Maharashtra, India.
J Res Med Sci. 2025 Mar 29;30:18. doi: 10.4103/jrms.jrms_550_24. eCollection 2025.
The production of specific antibodies occurs in response to pathogens, whether encountered naturally or introduced through vaccination, serving as markers of immunity. As novel vaccines are developed and deployed, especially in response to emerging infectious diseases, the ability to distinguish between vaccine-induced and infection-induced antibodies becomes increasingly important. Vaccines are designed to mimic this natural infection process without causing the disease itself. Serological assays are critical tools in immunology, enabling researchers and clinicians to differentiate between antibodies produced by vaccination and those generated by natural infection. By understanding whether an individual's antibodies are the result of previous infection or vaccination, healthcare providers can modify booster recommendations more effectively. It also plays an important role in identifying people with hybrid immunity and in assessing the effectiveness of vaccination campaigns.
特定抗体的产生是对病原体的反应,无论是自然接触还是通过疫苗接种引入,它都作为免疫的标志。随着新型疫苗的研发和部署,特别是针对新出现的传染病,区分疫苗诱导抗体和感染诱导抗体的能力变得越来越重要。疫苗的设计旨在模拟这种自然感染过程而不引发疾病本身。血清学检测是免疫学中的关键工具,使研究人员和临床医生能够区分疫苗接种产生的抗体和自然感染产生的抗体。通过了解个体的抗体是先前感染还是疫苗接种的结果,医疗保健提供者可以更有效地调整加强针的建议。它在识别具有混合免疫力的人群以及评估疫苗接种运动的有效性方面也发挥着重要作用。